DD266921A3 - Sauermilchprodukt "bifilin" - Google Patents

Sauermilchprodukt "bifilin" Download PDF

Info

Publication number
DD266921A3
DD266921A3 DD85273191A DD27319185A DD266921A3 DD 266921 A3 DD266921 A3 DD 266921A3 DD 85273191 A DD85273191 A DD 85273191A DD 27319185 A DD27319185 A DD 27319185A DD 266921 A3 DD266921 A3 DD 266921A3
Authority
DD
German Democratic Republic
Prior art keywords
pacthtejibhoro
mjih
milk
mji
bifilin
Prior art date
Application number
DD85273191A
Other languages
English (en)
Inventor
Evgenija A Chorkova
Vera F Semenichina
Lilia N Ivanova
Marina B Sundukova
Kalerija S Ladodo
Natalja N Semenova
Svetlana M Barasneva
Original Assignee
Vnimi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vnimi filed Critical Vnimi
Publication of DD266921A3 publication Critical patent/DD266921A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Die Erfindung betrifft die Molkereiindustrie. Das Sauermilchprodukt enthaelt Eiweissstoffe, Milchfett, Lactose, Minderalstoffe, Vitamin A, Bifidusbakterien und Wasser. Erfindungsgemaess enthaelt das Produkt zusaetzlich Maltodextrin, Saccharose, Pflanzenfett und die Vitamine D2, E, C, B1, B2, B3, B6, BC und PP. Als Mineralstoffe wird ein Eisenpraeparat bei folgenden Verhaeltnissen der Bestandteile in Masseteilen (in %) verwendet:Milch- und Pflanzenfett 3,4...3,6Lactose2,0...2,2Maltodextrin1,6...1,8Saccharose3,3...3,5Eiweissstoffe1,6...1,8WasserRest (zu 100)Bifidusbakterien, Zelleinheiten in 1 ml108...109Eisensulfatpraeparat, ppm32,5...33,5Vitamine, ppm64,0...66,0

Description

OIMCAHHE H30EFETEHHfl K ABTOPCKOMy
: ,29.02,84 J5. 3706834/28-03 MM4 A23C 9/12
E.A.XopBKOBa, B.ö.CeMeHHXHHa, Jl*H.HBaHOBa, M.B.CyiWKOBa, K.C.üaÄOÄO, H.W.CeMeHOBa, C.M.BapaiiiHeBa
BcecoK)3HHH Hay^o-nccjieitOBaTejiBCKHK
MOJIOTOOä npOMHUUieHHOCTH
Ha3EaHne ii30ÖpeTeHHH: KWCJIOMOJIOmii'l ΠΡΟ,Ε,ΤΚΓ "
Pl3OOpeTeHHe OTKOCHTCH Κ MOJlO^HOa ΠρΟΜΗΙΐυίβΗΗΟΟΤΗ H MOJKeT OHTB HCnOJIB3OBaHO npE npOH3BOÄCTBe
ηογο npoiyKTa jyiß ΛβτοκοΓΟ jie-qeoHoro nnTaH üejiBio H30Öpe TeHHJJ flBJiseTCH noBHmeHne ueHHOCTH n jie^ieoHHx cboSctb npojiyKTa. CynmocTB n300peTeHHH 3aKjn(raaeTcii B tom, ^to προ-ÄonojiHPiTe-iBHO coÄepKHT ÄeKCTpnH-MajiBTOsy, caxapo-3y, pacTHTeJiBHHii amp, BHTawniHH D1, E, C, Bj, Bg, B3, Bg, B0, PP, a β Ka^e CTBe MHHepaJiBHbix BemecTB HcnojtB3y-MT npenapaT atejie3a npn cjie^yiomiix cooTHOineHHHx κομποηθη-TOB B MaCC.aOJlHX %\
MOJIO^HHÜ H pa CTHTeJIBHHH
JKHpH 3,4-3,6
jiaKT03a 2,0-2,2
jte KcTpHH-MajiBT 03a 1,6-1,8
caxapo3a 3,3-3,5
1,6-1,8
B TOM ^HCJIe
Q Q
ΟΒφΗΗΟΟβκτβρκβ, eÄ,KJieTOK β I mji IO -IO npenapaT cepHOKHCJioro scejie3a,
MJiH"1 32,5-33,5
BHTaMHHH, MJIH 64,0-66,0,
Γ· 1 CJ q 7
py3Hoe ηλη κοκοcoboe itjik no^cojiHe^HOe ii MacJio η cooTHOiueHHe mojiohhoio h paCTHTejiBHoro
3:1
CooTHOineHiie μολο^ϊηογο η pacTHTejiBHoro ehpob - 3:1
otiTHMaJiBHEM, TaK KaK no αθηηημ ne^HaTpoB ημθη-HO 25% pacTwreJiLHoro >mpa, saMeKHHiiero mojkhhhh, ποκρκ-BaeT He^ocTaTOK β nojiHHeHacuiüeHHHX ÄHpHbix KHCJioTax, κο-Topue OTCyTCTBJTK)T β mojiohhom stupe η ηθοοχο,ιιημη άπα noji-
ΗΟΙίβΗΗΟΓΟ pa3BHTHH JteTCKOPO 0ρΓ8ΗΗ3Μβ. ΠρΜΜβρ Ι.
K 387 κγ MOJiOKa c MaccpEoft ÄOJieii Knpa 3,655, ÖejiKa 3,2^ κ 40,2 κγ CJDiBOK c MaccoBOü AOJieli Hnpa 30$, öejnca 2% jioöaBJiaioT 9 κγ KyKypy3Horo Macjia, npejtBapHTejiiHO ΒΗΘCH B Hero E 333HCHIZiOCTH OT ΚΟΗΙΙβΗΤΌβΙΙΗΗ B MaCJIHHOM pacTBope xnpopacTBopHMHe BHTaMHHH A1Ji2, Ξ ho: 0,0005, O1OOCOI, 0,0085 κγ.
JI1JiH nojirqeHHfl MejiKO^HcnepcKoit jsicoboh
MOJlOiJEXHKHpOByK) OCHOBy ΓΟΜΟΓΘΗΕ3Ηρ7!0Τ ΙΊ CMeiDI'IEaiOT C paCT ΒΟρΟϊί yrjieBOÄHHX ΚΟΜΠΟΗβΗΤΟΕ. ÄJ1H ΟΗΗΗβΗΗΗ opOJ3.HJIi.HHX CBOHCTB JiaKT03H ΚΟρΟΒΒβΓΟ MOJIOKa B CMeCi ÄOOaBJlflKT
34.4 κγ caxapa-necKa (3,44^ onTHMajiBHOe -3Ha^eHHe) H
22.5 KT cojiOÄOBoro aKCTpaKTa c MaccoBOß aojiea cyxHx BeuteCTB - 74$, ^ϊτο cooTBeTCTByeT 17 κτ cyxoii MaJILTOSH HJiH 1,7%, Bcero AOOaEJiHeT 7,0^ yrjiesoÄOB.
BOÄHHM KOMIlOHeHT - ΑβΚΟΤρΗΗ-ΜβΛΐΤΟββ, ΗΜβΗΗΟ 1,7% OÖeC-pOCT όΗφΗΑΟόβΚΤβρΗϋ npH CKBaiHHBaHEH.
pacTBopHßT B 406,9 κτ πητβθβοΓι bo^h c τθμ-nepaTypofi 500C, φΐυΐΒτργτοτ. CMeuuiBaiOT c roMoreHHSHpoBaH-höh npH 20 MIIa μολοώιο-χιιροβοη ocHOBoä. IIacTepH3yioT npn TewinepaType 950C (Biwepaaca 30 MHHyr) a- oxnaswaKT άο τβΜ-nepaTypu 400C. Bhocht IO/o 3aKsacKH ^hcthx KyjiBTyp οηφη-ÄOöaKTepzÄ, npenapaT cepHOKHCJioro aejie3a (Π) - 0,033 η BOÄOpaCTEOpHMHe BHTaMHHH B ΚΓ! C - 0,05, FP - 0,004, B6 - 0,0002, B1 - 0,0003, B2 - 0,0001, B3 - 0,0015, B0 - 0,00004. GviecB CKBauiHBaioT πρίί TewnepaType 370C
U8F7- -57Γ3-Ϊ
0,0015, Bc - 0,00004. CMecB cKBaiittiBaioT πρπ TeMnepaType 370C ao khcjiothocth 5O0T, 3aTeM nepeMemnBaioT η HanpaB-JIHiOT na PO3JMB. Pa3JfflBai-0T προΑΥΚτ β rpajiyHpoBaHHHe Oy-THJKHKH BMe CTHMO CTBK) 200 MJI, ΥΚ/ΠΟρίΙΒαΙΟΤ H HanpaBJIHMT Ha oxjiaaweHHe, β xojioAHjiBHyio KaMepy.
KhCJIOMOJIO^HHH npOffiTKT '1BHCPHJIHH1^nPeACTaBJlHeT CQÖOä
ojcHopojmyio Maccy c jierraiM χ^οπβθβηαηημ HapynieHHHM crycT-HMeeT WCTHJi KHCJIOMOJIOtIHHt CJISAKOBaTHZ BKyC, C npHBKycoM cojiOBOBoro 3KCTpaKTa η jieTy^nx khcjiot. npojtyKTa - MOJioHHO-oejiHu hjih κρβΜ0ΒΗίίο Khcjiothoctb β npe^ejiax 50-650T. CocTaB npo,nyKTa
K JKeHCKOMy MOJIOKy, flaeT BO3M0KHOCTB erO B Ka^eCTBe IlHTaHHH npn HCKyCCTSeHHOM ^eTeH co jjhh pojKfleHHH AO 2-x MecHiieB, a HH3Kan
KHCJIOTHOCTB n03B0JIHeT ΠρΗΜβΗΗΤΒ ΘΓΟ ,HJIfI BCKapMJIHBaHHH HeAOHonieHHBix iteTet. Khcjiomojio^hhm npo^yKT COAepSCaiUHH Β I MJI ^o IO 2CHBHX KJieTOK HBJIHeTCH 3φφβΚΤΗΒΗΒΙΜ Jie^eOHHM Cpe^CTBOM ΠρΗ cMeiiiaHHOM n TpyiiHOM BCKapMJiHBaHHH ^eTeH οτ O I ro,a;a.
CpaBHHTejiBHHe AaHHHe no q?H3HK0-xnMiraecK0My H MHKpOOHOJIOrH^eCKOMy COCTaBy H3BeCTHHX H
Taojnma I
a SeHCKoe ΑπηαοΦ^β- Khcjiomojio^i- Khcjiomojio^-
noKa3aTejief mojioko nan CMecB hhS ηθπητοκ ηηη ποο,ιπγκτ
"MajiiOTKa" "Mapyiympy" "ΒπφΐϋΐΗΗ"
(aHajicr) (προτοτΗπ)
HcnojiB3yeMaa HaTypajiB- cyx°e ueJiB- HaTypajiBHoe
MOJIO-^HaH HOe MOJIO- HOe MOJIOKO MOJIOKO
OCHOBa KO, · CJIHBKH
CJIHBKH
3aKBacKa Ha anHSOgmiB- οκφΗΑΟόακ- öHomno-
^hcthx KyjiB- HHe OaKTe- Te pirn OaicTepnn
Typax pun
V\
ι. Ι ο i ^ ! •a ! I 4 • j 5
KojnreecTBO
KHBHX KJie-
TOK B I MJI
npo,nyKTa 10' IO
KHCJIOTHOCTB,
Om 50-70 50-65
pH - 4,3-4,4 5,3-5,4 4,6-4,7
MaccoBaa AOJIfI, %
SUP 3,5 3,5 3,3 3,5
Be JiOK 1,V-1,8 1,7 3,3 1,6-1,7
yrjieBOÄH 7,0 7,0 11,0 7,0
B TOM
jiaKTOsa 7,0 2,0-2,2 4,8 2,0-2,2
Caxaposa - 3,4 - 3,4
mmhfoST — 1,7
rjiK)K03a — — 2,9
φΡ3ΓΕΓΓΟ3α - 2,5 -
BHTaMHHH A„a2,E,c, A A,Ä2,E,C,
B3»B6'Bc B3 »Bc »B6
npenapaT — rjnme ρο CepHOKHC-
X6JI63a , φό cc5aT TSJUiL JIO w ΛνΘ JXO 3 O
-I caxapaT \ JJJ BQJISHT"
X6JI63a Hoe (33,0)
33,0
B Taöjnme 2 npejicTaBJieHa 3aBHCHM0CTi> khcjiothocth η όκφΐηοόακτθρίΐίί β γοτοβομ npo^yKTe οτ προΐίθΗΤ-
ΗΟΓΟ, COaepJKaHHfl B ΗβΜ
; ο C 7
ZCiSZI
Taöjnma 2
% coßepjKamtö KiicJioTHocTi>, T 3a KojnreecTBO οΉφΗΛοόβκ-
ΒΘΚΟΤρΗΗ- 7 ^aC CKBailIHBaHHH TepHH B I MJI fOTOBO-
MaJEbTO3H Γ0 npOÄJTKTa
. 0,6 ' S ' 8,2-I0ö "
0,8 50 I-IO9
. 1,2 60 3·Ι09
1,7 65 5-I09
2 II BHme - TeMHHM IiBeT CMeCH, CIUILHHM npHBKyC COJIOÄOEOrO 3KCTDSKTa
1 Γ

Claims (4)

  1. ZU
    ο'ϋΑ Ή30ΒΡΞΤΕΗΚΗ
    üiiüi dejiKH, m
    »up, jiaKT037, MHHepajiBHHe Beii;ecT3a, BHTaMHH A, epHH κ souy, oTjnnaiamiäoH τθμ, ψιό, c nejiBio onojionreecKOH iieHHOcTH η jieneoHKX cBOKCTB oh itonojiHHTejiBHO coflepsKHT ^eKcrpKH-MajiBTOsy, caxapo3y, paCTHTeJiBHHiI siip, BHTaMHHH JI2,E1C,Bj· ,Bp,Bg1Bg^B0,PP, a β KaHecT3e MHHepajiBHtix semscTB ncnojiBsyioT npenapa? sejie30 npn cjieayramix οοοτηοιιιθηηηχ iinrpejuieHTOB b Mace.
    MOJIO^iHi! H paCTPtTeJIBHUH AHpH 3,4-3,6
    jiaKT03a · 2,0-2,2
    .ÄeKCTpHHHwaJii)T03a 1,6-1,8
    caxapo3a 3,3-3,5
    oejiKH : 1,6-1,8
    BO.ua ·
    β I mji IO°-IO
    npenapaT cepHOKHCJioro mejiesa, mjih 32,5-33,5
    BHTaMHHtI, MJIH-"1 64,0-66 , O.
  2. 2. Khcsjioi4Ojio^hh2 προ£7κτ no n.I, β Ka^:ecTBe pacTHTejiBHoro sapa HcnojiB3yicT KyKypy3Hoe
    HJIH KOKOCOBOe IiJIH 110,1!.COJIHeHHOe HJlH OJOIBKOBOe MaCJIO,
    cooTHOcieHHe μο.ιοηηογο η pacTHTejiBHoro scnpos y 3:1.
    ÜCTO^HHKH HHQTQpwauHH, ΠρΠΗΏΤΗΘ EO ΒΗΗΜβΗΗβ
  3. 1. CMecH aiiHnoÄiuiLHüe; "MajnoTKa" ii ",
    TY 49650-80, EEefleHH 01.03·. 80- ' · .
  4. 2. SypHaJi New Food Industry 1978, T .20, B 8, c. 17-23, H
    1 ] Q Q 7 . /. ~ "7 C Q .;
DD85273191A 1984-02-29 1985-02-12 Sauermilchprodukt "bifilin" DD266921A3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU843706834A SU1351560A1 (ru) 1984-02-29 1984-02-29 Кисло-молочный продукт "бифилин

Publications (1)

Publication Number Publication Date
DD266921A3 true DD266921A3 (de) 1989-04-19

Family

ID=21105860

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85273191A DD266921A3 (de) 1984-02-29 1985-02-12 Sauermilchprodukt "bifilin"

Country Status (14)

Country Link
JP (1) JPS61501247A (de)
AU (1) AU4155485A (de)
BG (1) BG46918A1 (de)
CA (1) CA1227082A (de)
CS (1) CS93585A1 (de)
DD (1) DD266921A3 (de)
DE (2) DE3590083C2 (de)
FI (1) FI853814A0 (de)
FR (1) FR2560013B1 (de)
GB (1) GB2171586B (de)
IT (1) IT1189721B (de)
SE (1) SE451938B (de)
SU (1) SU1351560A1 (de)
WO (1) WO1985003848A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
SE9803698L (sv) 1998-10-26 2000-04-27 Ericsson Telefon Ab L M Metoder och anordningar i ett telekommunikationssystem
US6383534B1 (en) * 2000-01-18 2002-05-07 Lorin Dyrr Mineral water composition
FI123158B (fi) * 2009-05-04 2012-11-30 Valio Oy Maitoproteiinituote ja menetelmä sen valmistamiseksi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1948378A1 (de) * 1969-09-24 1971-04-01 Rolf Dr Schuler Verfahren zur Herstellung vitaminierter Milcherzeugnisse
SU448852A1 (ru) * 1973-06-29 1974-11-05 Институт Питания Академии Медицинских Наук Ссср Способ производства сухой питательной смеси дл вскармливани детей раннего возраста
SU483100A1 (ru) * 1973-12-17 1975-09-05 Институт питания АМН СССР Способ производства кисломолочной питательной смеси дл вскармливани недоношенных и больных детей раннего возраста
JPS5283975A (en) * 1976-01-01 1977-07-13 Yakult Honsha Kk Method of producing fermented milk product containg living cell of bifidus strain
CH621048A5 (de) * 1977-04-27 1981-01-15 Nestle Sa
SU663364A1 (ru) * 1977-05-27 1979-05-25 Институт Питания Академии Медицинских Наук Способ производства пастообразного кисломолочного продукта дл вскармливани детей раннего возраста
SU863639A1 (ru) * 1979-12-25 1981-09-15 Всесоюзный Научно-Исследовательский Институт Молочной Промышленности Штамм бифидобактерий вIFIDовастеRIUм аDоеSсеNтIS мс-42,используемый дл приготовлени кисломолочных продуктов и способ получени закваски бифидобактерий дл кисломолочных продуктов
AR231215A1 (es) * 1982-06-15 1984-10-31 Cpc International Inc Procedimiento para la preparacion de un producto lacteo acidificado y producto asi obtenido

Also Published As

Publication number Publication date
FI853814L (fi) 1985-10-02
BG46918A1 (en) 1990-04-16
IT1189721B (it) 1988-02-04
CS93585A1 (en) 1988-02-15
FI853814A0 (fi) 1985-10-02
DE3590083T (de) 1986-03-13
GB2171586B (en) 1988-06-15
IT8541522A0 (it) 1985-02-28
AU4155485A (en) 1985-09-24
WO1985003848A1 (en) 1985-09-12
GB8523399D0 (en) 1985-10-23
DE3590083C2 (de) 1990-06-21
SE8504488L (sv) 1985-09-27
SE451938B (sv) 1987-11-09
CA1227082A (en) 1987-09-22
GB2171586A (en) 1986-09-03
SU1351560A1 (ru) 1987-11-15
FR2560013A1 (fr) 1985-08-30
JPS61501247A (ja) 1986-06-26
FR2560013B1 (fr) 1989-12-15
SE8504488D0 (sv) 1985-09-27

Similar Documents

Publication Publication Date Title
Arqués et al. Antimicrobial activity of reuterin in combination with nisin against food-borne pathogens
Nitschke et al. Recent food applications of microbial surfactants
US3929990A (en) Microbiocidal polymeric quaternary ammonium compounds
Von der Weid et al. Antimicrobial activity of Paenibacillus peoriae strain NRRL BD‐62 against a broad spectrum of phytopathogenic bacteria and fungi
Zheng et al. Isolation, partial purification and characterization of a bacteriocin produced by a newly isolated Bacillus subtilis strain
Hohnadel et al. Specificity of pyoverdine-mediated iron uptake among fluorescent Pseudomonas strains
EP0835120B2 (de) Verwendung eines ätherischen öles enthaltend thymol und carvacrol zur herstellung einer pharmazeutischen zubereitung zur behandlung oder prophylaxe von kokzidiose bei geflügel
ME00009B (de) Suspensionskonzentrate auf ölbasis
MY116272A (en) Immunity enhancing lactic acid bacteria
DK1010372T3 (da) Bageriprodukter omfattende levende lyofiliserede mælkesyrebakterier
US20080125496A1 (en) Antimicrobial flavor and oral care composition containing the same
DD266921A3 (de) Sauermilchprodukt "bifilin"
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
DD301912A9 (de) Nisin-Zusammensetzungen fuer die Anwendung als aktivierte Breitspektrumbakterizide
CY1108646T1 (el) Προβιοτικο βακτηριο γαλακτικου οξεος για την αντιμετωπιση βακτηριακων λοιμωξεων συνδεομενων με sids
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
NO20063410L (no) Probiotiske tablettformuleringer
BR9809000A (pt) Combinações antimicrobianas de sorbato, natamicina de dicarbonato de dialquila para uso em produtos alimentìcios
HRP20110933T1 (hr) Dugotrajni probiotički prehrambeni proizvod
DE69812922D1 (de) Verdickungsmittel enthaltende, vergiessbare fettzusammensetzungen
ATE399471T1 (de) Formulierung auf phospholipidbasis
E. Gustafson, Sean D. Cox, Yoon C. Liew, S. Grant Wyllie, John R. Warmington The bacterial multiple antibiotic resistant (Mar) phenotype leads to increased tolerance to tea tree oil
KR101987291B1 (ko) 항균성 세제 조성물
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
US8673865B2 (en) Agent for enhancing antiseptic power

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee
ENJ Ceased due to non-payment of renewal fee